JP2022505468A5 - - Google Patents
Info
- Publication number
- JP2022505468A5 JP2022505468A5 JP2021521511A JP2021521511A JP2022505468A5 JP 2022505468 A5 JP2022505468 A5 JP 2022505468A5 JP 2021521511 A JP2021521511 A JP 2021521511A JP 2021521511 A JP2021521511 A JP 2021521511A JP 2022505468 A5 JP2022505468 A5 JP 2022505468A5
- Authority
- JP
- Japan
- Prior art keywords
- soluble
- ecm
- composition according
- composition
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024129889A JP7864162B2 (ja) | 2018-10-25 | 2024-08-06 | 可溶性細胞外マトリックス組成物および血管内送達のための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862750303P | 2018-10-25 | 2018-10-25 | |
| US62/750,303 | 2018-10-25 | ||
| PCT/US2019/058052 WO2020086955A1 (en) | 2018-10-25 | 2019-10-25 | Soluble extracellular matrix composition and method for intravascular delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024129889A Division JP7864162B2 (ja) | 2018-10-25 | 2024-08-06 | 可溶性細胞外マトリックス組成物および血管内送達のための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022505468A JP2022505468A (ja) | 2022-01-14 |
| JP2022505468A5 true JP2022505468A5 (enExample) | 2022-08-19 |
| JP7536004B2 JP7536004B2 (ja) | 2024-08-19 |
Family
ID=70330739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521511A Active JP7536004B2 (ja) | 2018-10-25 | 2019-10-25 | 可溶性細胞外マトリックス組成物および血管内送達のための方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210379245A1 (enExample) |
| EP (1) | EP3870192A4 (enExample) |
| JP (1) | JP7536004B2 (enExample) |
| CN (1) | CN112867499A (enExample) |
| AU (1) | AU2019363610B2 (enExample) |
| CA (1) | CA3117688A1 (enExample) |
| WO (1) | WO2020086955A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022056437A1 (en) * | 2020-09-14 | 2022-03-17 | The Regents Of The University Of California | Compositions and methods of use for infusible extracellular matrix |
| KR102958487B1 (ko) * | 2023-04-06 | 2026-04-27 | 주식회사 메디팹 | 초임계 이산화탄소 공정 기반 수용성 탈세포 기질 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2608777T3 (en) * | 2010-08-24 | 2019-10-28 | Univ California | Compositions and Methods for Cardiac Therapy |
| WO2015164728A1 (en) * | 2014-04-24 | 2015-10-29 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Fractionating extracellular matrix to modulate bioactivity and the host response |
| KR101628821B1 (ko) | 2015-03-02 | 2016-06-13 | 강원대학교산학협력단 | 탈세포화된 생체 조직 유래의 생체적합성 가용화 스캐폴드 추출물, 이의 제조방법 및 이의 용도 |
| EP3402876B1 (en) * | 2016-01-13 | 2021-10-13 | University of Pittsburgh- Of the Commonwealth System of Higher Education | Vascular extracellular matrix hydrogel |
| AU2018226871B2 (en) * | 2017-03-02 | 2023-08-10 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Extracellular matrix (ECM) hydrogel and soluble fraction thereof for the treatment of cancer |
| EP3755267B1 (en) * | 2018-02-22 | 2024-06-12 | University of Pittsburgh - of the Commonwealth System of Higher Education | Extracts for the regeneration of ligaments |
-
2019
- 2019-10-25 JP JP2021521511A patent/JP7536004B2/ja active Active
- 2019-10-25 EP EP19876046.4A patent/EP3870192A4/en active Pending
- 2019-10-25 AU AU2019363610A patent/AU2019363610B2/en active Active
- 2019-10-25 CN CN201980067713.0A patent/CN112867499A/zh active Pending
- 2019-10-25 CA CA3117688A patent/CA3117688A1/en active Pending
- 2019-10-25 WO PCT/US2019/058052 patent/WO2020086955A1/en not_active Ceased
- 2019-10-25 US US17/286,534 patent/US20210379245A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel | |
| Nguyen et al. | Developing injectable nanomaterials to repair the heart | |
| Moelker et al. | Intracoronary delivery of umbilical cord blood derived unrestricted somatic stem cells is not suitable to improve LV function after myocardial infarction in swine | |
| Hu et al. | Hyaluronidase-powered microneedles for significantly enhanced transdermal delivery efficiency | |
| HRP20220336T1 (hr) | Postupak izoliranja i liofilizacije vanstaničnih vezikula | |
| CN115887419A (zh) | 一种载药微针贴片及其应用 | |
| EP4523713A1 (en) | Injectable anti-heart failure hydrogel having myocardial tissue repair functionality, method for preparing same, and use thereof | |
| US20210052663A1 (en) | Compositions and Methods for Treatment of Cardiovascular Disorders | |
| US12281330B2 (en) | Adaptation of hollow-fiber-based cell culture technology for the manufacturing of (1) neo-islets, employed for the treatment of type 1 and type 2 diabetes mellitus, and (2) the generation of exosomes from various cell types, used in the treatment of different organ injuries and diseases | |
| Joshi et al. | Nanofibers based tissue engineering and drug delivery approaches for myocardial regeneration | |
| KR20190102011A (ko) | 상피-중간엽 전이를 예방 또는 최소화하는 방법 및 조성물 | |
| CN115634363B (zh) | 可溶性分层微针、鼻腔给药载体、鼻腔给药系统及制备方法 | |
| KR101610732B1 (ko) | 약물 전달체 및 이를 포함하는 구강건조증 치료를 위한 약학적 조성물 | |
| CN115725500A (zh) | 脂肪间充质干细胞外泌体、其制备方法及其应用 | |
| JP7536004B2 (ja) | 可溶性細胞外マトリックス組成物および血管内送達のための方法 | |
| KR102630220B1 (ko) | 유도만능줄기세포-유래 중간엽 줄기세포 전구세포로부터 유래된 엑소좀을 포함하는 신장 질환의 예방 또는 치료용 조성물 | |
| EP2431046A1 (en) | Use of olive leaf extracts in a pharmaceutical composition for inducing angiogenesis and vasculogenesis | |
| Ieishi et al. | The effect of G-CSF in a myocardial ischemia reperfusion model rat | |
| Fu et al. | Hydrogel–exosome complexes: a novel strategy for cardiovascular regeneration | |
| CN102429858A (zh) | 缓释bio/igf的复合水凝胶的制备方法及其应用 | |
| Sawa | Current status of myocardial regeneration therapy | |
| JP7864162B2 (ja) | 可溶性細胞外マトリックス組成物および血管内送達のための方法 | |
| CN101301306A (zh) | Dft在制备治疗和预防休克药物中的应用 | |
| US20160024249A1 (en) | Temperature-Responsive Polymer Compositions and Methods of Use | |
| US20230398195A1 (en) | Composition derived from mammalian umbilical cord and whartons jelly for use in therapeutic and regenerative applications |